Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 6:47 PM UTC
| NCT Number | NCT07030257 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 150 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Tasca Therapeutics |
| Last Updated on CT.gov | February 18, 2026 (Feb 18, 2026) |
As of July 20, 2026: Clinical trial NCT07030257 is currently recruiting participants. This phase1 study for solid tumors is actively seeking new participants at 13 locations across the United States. The study is sponsored by Tasca Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07030257 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07030257 was last updated Feb 18, 2026 (February 18, 2026). HelloStudys verifies this status automatically.